Focus on Psychosis

The objective of the Focus on Psychosis section is to promote scientific research that impacts the clinical care of individuals with psychotic disorders and related conditions. Topics may pertain to conditions across the continuum of psychosis (eg, disorders in the schizophrenia spectrum or psychosis in mood and other psychiatric disorders) and at any stage of illness (eg, high-risk, first-episode, chronic, and in recovery). We are especially interested in high-quality manuscripts describing well-designed and well-conducted studies relating to pharmacologic, somatic, psychosocial, cognitive, and complementary therapies. While basic and translational research studies in psychosis are not the focus of the journal, we strongly welcome studies that incorporate biological measures as a clinical outcome and/or that elucidate biological mechanisms associated with specific clinical outcomes.

We encourage authors to submit papers for consideration as a part of our Focus on Psychosis section. Please contact Ann K. Shinn, MD, MPH, at ashinn@psychiatrist.com.


 

ORIGINAL RESEARCH
ORIGINAL RESEARCH
ORIGINAL RESEARCH
ORIGINAL RESEARCH
ORIGINAL RESEARCH
ORIGINAL RESEARCH
ORIGINAL RESEARCH
META-ANALYSIS
ORIGINAL RESEARCH
ORIGINAL RESEARCH

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial

This RCT determined whether a single dose of sublingual dexmedetomidine reduced acute agitation associated with schizophrenia or...

Read More...